Gallium-68: A new trend in PET radiopharmacy

Current Radiopharmaceuticals

Volumn 5, Issue 2, 2012, Pages 142-149

  Prata, M Isabel M ^a  

^a UNIVERSITY OF COIMBRA   (Portugal)

Author keywords

68Ge 68Ga generator; Bioconjugates; Gallium 68; Nuclear probes; PET imaging

Indexed keywords

ALPHA INTERMEDIN; ARGINYLGLYCYLASPARTIC ACID; BOMBESIN; CHELATING AGENT; DEFEROXAMINE; GALLIUM 68; LYSINE; MELANOCORTIN 1 RECEPTOR; MONOCLONAL ANTIBODY; OCTREOTIDE; RADIOPHARMACEUTICAL AGENT; SOMATOSTATIN DERIVATIVE; SOMATOSTATIN RECEPTOR 2; TETRAXETAN; VITRONECTIN RECEPTOR;

ARTICLE; BINDING AFFINITY; BONE METASTASIS; CHEMICAL INTERACTION; CYCLOTRON; HUMAN; INTERMETHOD COMPARISON; ISOTOPE LABELING; MOLECULAR IMAGING; MOLECULAR RECOGNITION; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION;

ANTIBODIES, MONOCLONAL; CHELATING AGENTS; GALLIUM RADIOISOTOPES; HUMANS; INTEGRINS; MELANOCYTE-STIMULATING HORMONES; PEPTIDES; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS;

EID: 84857132022     PISSN: 18744710     EISSN: 18744729     Source Type: Journal    
DOI: 10.2174/1874471011205020142     Document Type: Article

References (82)

1. 68Ga-Labeled Oligonucleotides for In vivo Imaging with PET. J. Nucl. Med., 2004, 45, 347-355.
2. 68Ga-DOTA-hEGF for Visualization of EGFR Expression in Malignant Tumors. J. Nucl. Med., 2005, 46, 1881-1888.
3. 68Ga-PET: a powerful generator-based alternative to cyclotron-based PET radiopharmaceuticals. Contr. Med. Mol. Imag., 2008, 3, 67-77.
4. [Schoffelen, R.; Sharkey, R.M.; Goldenberg, D.M.; Franssen, G.; McBride, W. J.; Rossi, E.A.; Chang, C.; Laverman, P.; Disselhorst, J.A.; Eek, A.; van der Graaf, W.T.A.; Oyen, W.J.G.; Boerman, O.C. Pretargeted Immuno-Positron Emission Tomography Imaging of Carcinoembryonic Antigen-Expressing Tumors with a Bispecific Antibody and a Ga-68-and F-18-Labeled Hapten Peptide in Mice with Human Tumor Xenografts. Mol. Cancer Therap., 2010, 9, 1019-1027.
5. 68Ga for PET Imaging of HER2 Expression. J. Nucl. Med., 2009, 50, 1492-1499.
6. Lambrecht, R.; Sajjad, M.; Accelerator derived radionuclide generators. Radiochim. Acta, 1978, 43, 171-179.
7. Mirzadeh, S.; Lambrecht, R.; Radiochemistry of Germanium. J. Radioanal. Nucl. Chem., 1996, 202, 7-102.
8. 18F-Radiopharmacy. PET Chemistry, the driving force in Molecular Imaging. Springer-Verlag, Berlin, Heidelberg, 2007.
9. 68Ge using a macroporous organic polymer containing Nmethylglucamine groups. Anal. Chim. Acta, 2002, 453, 135-141.
10. Loc'h, C.; Maziere, B.; Comar, D. A new generator for ionic gallium-68. J. Nucl. Med., 1980, 21, 171-173.
11. Lambrecht, R.; Sajjad, M. Accelerator derived radionuclide generators. Radiochem. Acta, 1978, 43, 171-179.
12. 68Ga-bioconjugates with high specific radioactivity. Bioconj. Chem., 2004, 15, 554-560.
13. 68Ga-labeled radiotracers. Nucl. Med. Biol., 2007, 34, 121-127.
14. Anderson, C.J.; Welch, M.J. Radiometal-Labeled Agents (Non-Technetium) for Diagnostic Imaging. Chem. Rev., 1999, 2219-2234.
15. Green, M.A.; Welch, M.J. Gallium radiopharmaceutical chemistry. Nucl. Med. Biol., 1989, 435-448.
16. Bandoli, G.; Dolmella, A.; Tisato, F.; Porchia, M.; Refosco, F. Mononuclear six-coordinated Ga(III) complexes: A comprehensive survey. Coord. Chem. Rev., 2009, 253 (1 + 2), 56-64.
17. Pearson, R.G. Hard and Soft Acids and Bases. J. Am. Chem. Soc., 1963, 85, 3533-3539.
18. Harris, W.R.; Pecoraro, V.L. Thermodynamic binding constants for gallium transferrin. Biochemistry, 1983, 22, 292-299.
19. Dymov, A.M.; Seventin, A.P. Analytical Chemistry of Gallium, Ann Arbor Science Publishers, Michigan, 1970.
20. de Leon-Rodriguez, L.M.; Kovacs, Z. The synthesis and chelation chemistry of DOTA-peptide conjugates. Bioconj. Chem. 2008, 19, 391-399.
21. Hnatowich, D.J.; Childs, K.L.; Lanteigne, D.; Najafi, A. The preparation of DTPA-coupled antibodies radiolabeled with metallic radionuclides: an improved method. J. Immun. Meth., 1983, 65, 147-157.
22. Heppeler, A.; Froidevaux, S.; Eberle, A.N.; Maecke, H.R. Receptor Targeting for Tumor Localisation and Therapy with Radiopeptides. Curr. Med. Chem., 2000, 7, 971-994
23. Smith-Jones, P.M.; Stolz, B.; Bruns, C.; Albert, R.; Reist, H.W.; Fridrich, R.; Maecke, H.R. Gallium-67/gallium-68-[DFO]-octreotide-a potential radiopharmaceutical for PET imaging of somatostatin receptor-positive tumors: synthesis and radiolabeling in vitro and preliminary in vivo studies. J. Nucl. Med., 1994, 35, 317-325.
24. 68Ga-labeled Ga(III)-deferoxamine-folate as potential folatereceptor-targeted PET radiopharmaceuticals. Nucl. Med. Biol., 2003, 30, 725-731.
25. +. J.Nucl. Med., 1993, 34, 1127-1131.
26. 68Ga BAPEN kit for myocardial positron emission tomography imaging and biodistribution study. Nucl. Med. Biol., 2010, 37, 149-155.
27. Green, M.K.; Mathias, C.J.; Newmann, W.L.; Fanwick, P.E.; Janik, P.E.; Deutsch, E.A. Potential Gallium-68 Tracers for Imaging the Heart with PET: Evaluation of Four Gallium Complexes with Functionalized Tripodal Tris(Salicylaldimine) Ligands. J. Nucl. Med., 1993, 34, 228-233.
28. 67Ga-Labeled Species. J. Inorg. Biochem., 2010, in press
29. Clarke, E.T.; Martell, A.E. Stabilities of the Fe(III), Ga(III) and In(III) chelates of N, N', N''-triazacyclononanetriacetic acid. Inorg. Chim. Acta, 1991, 181, 273-280.
30. Broan, J.P.; Cox, L.; Craig, A.S.; Kataky, R.; Parker, D.; Harrison, A.; Randall, M.; Ferguson, G. Structure and solution stability of indium and gallium complexes of 1, 4, 7-triazacyclononanetriacetate and of ytrium complexes of 1, 4, 7, 10-tetraazacyclododecanetetraacetate and related ligands -kinetically stable complexes for use in imaging and radioimmunotherapy Xray molecular structure of the indium and gallium complexes of 1, 4, 7-triazacyclononane-1, 4, 7-triacetic acid. J. Chem. Soc. Perkin Trans., 1991, 2, 87-99.
31. [Ma, R.; Welch, M.J.; Reibenspies, J.; Martell, A.E. Stability of metalion complexes of 1, 4, 7-tris(2-mercaptoethyl)-1, 4, 7-triazacyclononane (Tacn-Tm) and molecular structure of in(C12H24N3S3). Inorg. Chim. Acta, 1995, 236, 75-82.
32. 3+ complexes of triaza macrocyclic ligands: biodistribution and clearance studies. Nucl. Med. Biol., 1999, 26, 707-710.
33. Prata, M.I.; Santos, A.C.; Geraldes, C.F.; de Lima, J.J. Structural and in vivo studies of metal chelates of Ga(III) relevant to biomedical imaging. J. Inorg. Biochem., 2000, 79, 359-63.
34. Andre, J.P.; Maecke, H.R.; Zehnder, M.; Macko, L.; Akyel, K.G. 1, 4, 7-triazacyclononane-1-succinic acid-4, 7-diacetic acid (NODASA): a new bifunctional chelator for radio gallium-labelling of biomolecules. Chem. Comm., 1998, 12, 1301-1302.
35. Subramanya, C.Y.; Sreerama, G.; Hsieh, W.; Liu, S. Synthesis and Characterization of a Novel Macrocyclic Chelator with 3-Hydroxy-4-Pyrone Chelating Arms and Its Complexes with Medicinally Important Metals. Inorg. Chem., 2008, 47, 2719-2727.
36. de Sá, A.; Prata, M.I.M.; Geraldes, C.F.G.C.; André, J.P. Triaza-Based Amphiphilic Bifunctional Chelators: synthetic route and in vivo Studies of their Ga(III) and Al(III) Chelates. J. Inorg. Biochem., 2010, 104, 1051-1062.
37. Clarke, E.T.; Martell, A.E. Stabilities of trivalent metal-ion complexes of the tetraacetate derivatives of 12-membered, 13-membered and 14-membered tetraazamacrocycles. Inorg. Chim. Acta., 1991, 190, 37-46.
38. Heppeler, A.; Froidevaux, S.; Maecke, H. R.; Jermann, E.; Béhé, M.; Powell, P.; Hennig, M. Radiometal-labelled macrocyclic chelator-derivatized somatostatin analogue with superb tumourtargeting properties and potential for receptor mediated internal radiotherapy. Chem. Eur. J., 1999, 5, 1974-1981.
39. 68Ga-DOTANOC: a first compound for PET imaging with high affinity for somatostatin receptor subtypes 2 and 5. Eur. J. Nucl. Med. Mol. Imag., 2005, 32, 724-724.
40. Bartholoma, M.D.; Louie, A.S.; Valliant, J.F.; Zubieta, J. Technetium and Gallium Derived Radiopharmaceuticals: Comparing and Contrasting the Chemistry of Two Important Radiometals for the Molecular Imaging Era. Chem. Rev., 2010, 110, 2903-2920.
41. Okarvi, S.M. Recent progress in fluorine-18 labelled peptide radiopharmaceuticals. Eur. J. Nucl. Med., 2001, 28, 929-938.
42. Signore, A.; Annovazz, A.; Chianelli, M.; Corsetti, F.; van de Wiele, C.; Watherhouse, R.N.; Scopinaro, F. Peptide radiopharmaceuticals for diagnosis and therapy. Eur. J. Nucl. Med., 2001, 28, 1555-1565.
43. 68Ga-Labeled Peptides in Tumor Imaging. J. Nucl. Med., 2005, 46, 172S-178S.
44. J.C. In vitro identification of vasoactive intestinal peptide receptors in human tumors: Implications for tumor imaging. J. Nucl. Med., 1995, 36: 1846-1853.
45. Maack, T.; Johnson, V.; Sen, T.K.; Figueiredo, J.; Sigulem, D. Renal filtration, transport, and metabolism of low-molecularweight proteins: a review. Kidney Int., 1979, 16, 251-270.
46. 68Ga-DOTATOC PET [image of the month]. Eur. J. Nucl. Med. Mol. Imag., 2004, 31, 466-466.
47. 68Ga-DOTATOC: preliminary data. Eur. J. Nucl. Med., 2001, 28, 1751-1757.
48. 111In]-DTPAOC SPECT. First results in patients with neuroendocrine tumors. Mol. Imag. Biol., 2003, 5, 42-48.
49. 68Ga. Eur. J. Nucl. Med. Mol. Imag., 2005, 32, 478-485.
50. 90YDOTATOC therapy. Eur. J. Nucl. Med. Mol. Imag., 2006, 33, 460-466.
51. 68Ga]-DOTATOC to somatostatin receptors in neuroendocrine tumours -impact of peptide mass. Nucl. Med. Biol., 2010, 37, 265-275.
52. 18F-FDG. Cancer, 2008, 112, 2447-2455.
53. 111In] for SPECT, PET, and targeted therapeutic applications of somatostatin receptor (hsst2) expressing tumors. Bioconj. Chem., 2002, 13, 530-541.
54. Reubi, J.C.; Waser, B. Concomitant expression of several peptide receptors in neuroendocrine tumours: molecular basis for in vivo multireceptor tumour targeting. Eur. J. Nucl. Med. Mol. Imag., 2003, 30, 781-793.
55. 68Ga-DOTA-NOC PET/CT in comparison with CT for the detection of bone metastasis in patients with neuroendocrine tumours. Eur. J. Nucl. Med. Mol. Imag., 2010, 37, 722-727.
56. 68Ga-DOTA-Tyr3-octreotide PET in comparison to CT and bone scintigraphy. J. Nucl. Med., 2009, 50, 1214-1221.
57. 68Ga]DOTA-D-Phe1-Tyr3-Octreotide: First Results in Patients with Meningiomas. J. Nucl. Med., 2001, 42, 1053-1056.
58. 68Ga-DOTA-DPhe1-Tyr3-octreotide kinetics in patients with meningiomas. J. Nucl. Med., 2005, 46, 763-769.
59. Folkman, J. Role of angiogenesis in tumour growth and metastasis. Semin Oncol., 2002, 29, 15-18.
60. Albelda, S. M.; Mette, S. A.; Elder, D.E.; Stewart, R.; Damjanovich, L.; Herlyn, M.; Buck, C.A. Integrin distribution in malignant melanoma: association of the β3 subunit with tumor progression. Cancer Res., 1990, 50, 6757-6764.
61. Bello, L.; Francolini, M.; Marthyn P.; Zhang J.; Carroll R.S.; Nikas D.C.; Strasser, J.F.; Villani, R.; Cheresh, D.A.; Black, P. αvβ3 and αvβ5 integrin expression in glioma periphery. Neurosurgery, 2001, 49, 380-389.
62. Brooks, P.C.; Stromblad, S.; Klemke, R.; Visscher, D.; Sarkar, F.H.; Cheresh, D.A. Antiintegrin αvβ3 blocks human breast cancer growth and angiogenesis in human skin. J. Clin. Invest., 1995, 96, 1815-1822.
63. Dijkgraaf, I.; Kruijtzer, J.A.; Liu, S.; Soede, A.C.; Oyen, W.J.; Corstens, F.H.; Liskamp, R.M.; Boerman, O.C. Improved targeting of the alpha(v)beta (3) integrin by multimerisation of RGD peptides. Eur. J. Nucl. Med. Mol. Imag., 2007, 34, 267-273.
64. Puduvalli, V.K. Inhibition of angiogenesis as a therapeutic strategy against brain tumors. Cancer Treat. Res., 2004, 117, 307-336.
65. 111Inlabelled DOTA-RGD peptides for imaging of αvβ3 integrin expression. Eur. J. Nucl. Med. Mol. Imag., 2008, 35, 1507-1515.
66. 68Ga-labeled multimeric RGD peptides for microPET imaging of integrin αvβ3 expression. Eur. J. Nucl. Med. Mol. Imag., 2008, 35, 1100-1108.
67. 68Galabeled cyclic RGD dimers with Gly3 and PEG4 linkers: promising agents for tumor integrin αvβ3 PET imaging. Eur. J. Nucl. Med. Mol. Imag., 2009, 36, 947-957.
68. 68Ga Labeled RGD-Bombesin Heterodimeric Peptides for PET Imaging of Breast Cancer. Bioconj. Chem., 2009, 20, 1016-1025.
69. 68Ga-labeled NOTA-RGDBBN peptide for dual integrin and GRPR-targeted tumor imaging. Eur. J. Nucl. Med. Mol. Imag., 2008, 35, 1100-1108.
70. Wei, L.; Miao, Y.; Gallazzi, F.; Quinn, T.P.; Welch, M.J.; Vavere, A.L.; Lewis, J.S. Gallium-68-labeled DOTA-rhenium-cyclized α-melanocyte-stimulating hormone analog for imaging of malignant melanoma. Nucl. Med. Biol., 2007, 34, 945-953.
71. Froidevaux, S.; Calame-Christe, M.; Tanner, H.; Eberle, A.N. A Gallium-Labeled DOTA-α-Melanocyte-Stimulating Hormone Analog for PET Melanoma Targeting with DOTA-α-Melanocyte-Stimulating Hormone Analogs: Structural Parameters Affecting Tumor Uptake and Kidney Uptake. J. Nucl. Med., 2005, 46, 887-895.
72. 68Ga-DOTAVAP-P1 PET imaging capable of demonstrating the phase of inflammation in healing bones and the progress of infection in osteomyelitic bones. Eur. J. Nucl. Med. Mol. Imag., 2008, 35, 352-364.
73. 68Ga-DOTAVAP-PEG-P2 peptide targeting vascular adhesion protein-1. Clin. Pysiol. Funct. Imag., 2010, 30, 75-78.
74. Wild, D.; Wicki, A.; Mans, R.; Béhé, M.; Keil, B.; Bernhardt, P.; Christofori, G.; Ell, P.J.; Maecke, H.R. Exendin-4-Based Radiopharmaceuticals for Glucagonlike Peptide-1 Receptor PET/CT and SPECT/CT. J. Nucl. Med., 2010, 51, 1059-1067.
75. Meares, C. Chelating agents for the binding of metal ions to proteins. Nucl. Med. Biol., 1986, 13, 311-318.
76. 68Ga-Radiolabeled Bivalent Hapten-Peptide-Chelate Conjugates. J. Nucl. Med., 2004, 45, 30-39.
77. Klivenyi, G.; Schuhmacher, J.; Patzelt, E.; Hauser, H.; Matys, R.; Moock, M.; Regiert, T.; Maier-Borst, W. Gallium-68 chelate imaging of human colon carcinoma xenografts pretargeted with bispecific anti-CD44(V6) anti-gallium chelate antibodies. J. Nucl. Med., 1998, 39, 1769-1776.
78. Schuhmacher, J.; Kaul, S.; Klivenyi, G.; Junkermann, H.; Magener, A.; Henze, M.; Doll, J.; Haberkorn, U.; Amelung, F.; Bastert, G. Immunoscintigraphy with Positron Emission Tomography: Gallium-68 Chelate Imaging of Breast Cancer Pretargeted with Bispecific Anti-MUC1/Anti-Ga Chelate Antibodies. Cancer Res., 2001, 61, 3712-3717.
79. Erb, D.A.; Nabi, H.A. Clinical and technical considerations for imaging colorectal cancers with techenetium-99-m-labeled antiCEA Fab fragment. J. Nuc. Med. Tech, 2000, 28, 12-18.
80. Welch, M.J.; Thakur, M.L.; Coleman, R.E.; Patel, M.; Siegel, B.A.; Ter-Pogossian, M. Gallium-68 labelled red cells and platelets: new agents for positron tomography. J. Nucl. Med., 1977, 18, 558-562.
81. 68Ga-labelled PET tracer. Eur. J. Nucl. Med. Mol. Imag., 2010, 37, 1935-1942.
82. 68Ga-labelled tracers in clinical routine? Eur. J. Nucl. Med. Mol. Imag., 2007, 34, 978-981.